Clincosm LogoSign in Get a demo

kras gene mutation

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

KRAS Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • KRAS Gene Mutation
  • +2 more
  • Anchorage, Alaska
  • +604 more
Jan 28, 2023

KRAS Gene Mutation Trial in Cincinnati, Dallas (TVB-2640)

Recruiting
  • KRAS Gene Mutation
  • Cincinnati, Ohio
  • +1 more
Dec 19, 2022

EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

Recruiting
  • EGFR NP_005219.2:p.S492R
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • KRAS Gene Mutation
  • Phoenix, Arizona
  • +6 more
Nov 10, 2022

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Solid Tumors, NSCLC, CRC Trial in United States (Telaglenestat (CB-839), Palbociclib Oral Capsule or Tablet [Ibrance])

Completed
  • Solid Tumors
  • +3 more
  • Telaglenestat (CB-839)
  • Palbociclib Oral Capsule or Tablet [Ibrance]
  • Santa Monica, California
  • +9 more
Sep 14, 2022

French National Observatory of Non-small Cell Lung and Molecular

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +3 more
    • Agen, France
    • +132 more
    Jun 29, 2022

    Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations, NSCLC, KRAS Gene Mutation Trial in Santa Monica,

    Recruiting
    • Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations
    • +2 more
    • Futibatinib and Binimetinib
    • Santa Monica, California
    • +2 more
    Jun 2, 2022

    KRAS Gene Mutation, Metastatic Malignant Tumor in the Brain, Recurrent Non-Small Cell Lung Carcinoma Trial in Palo Alto

    Active, not recruiting
    • KRAS Gene Mutation
    • +3 more
    • Palo Alto, California
      Stanford University School of Medicine
    Feb 9, 2022

    OPTImal PALliative Anti-epidermal Growth Factor Receptor

    Active, not recruiting
    • Colorectal Cancer Metastatic
    • +5 more
    • Plasma circulating DNA analysis
    • Aarhus, Denmark
      Aarhus University Hospital
    Feb 24, 2022

    Non Small Cell Lung Cancer, KRAS Gene Mutation Trial in United States (Trametinib 0.5 mg, Trametinib 1 MG, Trametinib 1.5 MG)

    Completed
    • Non Small Cell Lung Cancer
    • KRAS Gene Mutation
    • Trametinib 0.5 mg
    • +5 more
    • Basking Ridge, New Jersey
    • +6 more
    Feb 7, 2022

    Advanced Malignant Solid Tumor, KRAS Gene Mutation, Ovarian Carcinoma Trial in Houston (Paclitaxel, Pharmacokinetic Study,

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2021

    KRAS Gene Mutation, Metastatic Non-Squamous Non-Small Cell Lung Carcinoma, Recurrent Non-Squamous Non-Small Cell Lung Carcinoma

    Active, not recruiting
    • KRAS Gene Mutation
    • +3 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Nov 1, 2021

    Advanced NSCLC, KRAS Gene Mutation, Lung Cancer Trial in Switzerland (Binimetinib, Pemetrexed, Cisplatin)

    Completed
    • Advanced Non-small Cell Lung Cancer
    • +2 more
    • Basel, Switzerland
    • +3 more
    Jul 13, 2021

    Infiltrating Urothelial Carcinoma, KRAS Gene Mutation Trial in France (Chemotherapy, Panitumumab)

    Completed
    • Infiltrating Urothelial Carcinoma
    • KRAS Gene Mutation
    • Bordeaux, France
    • +16 more
    Mar 4, 2021

    Metastatic Colorectal Cancer, KRAS Gene Mutation Trial (Onvansertib, Bevacizumab, FOLFIRI)

    No longer available
    • Metastatic Colorectal Cancer
    • KRAS Gene Mutation
    • (no location specified)
    Jan 18, 2021

    Frequency of EGFR and KRAS Mutations and Clinical-prognostic

    Completed
    • Lung Neoplasms
    • +2 more
      • Curitiba, Parana, Brazil
        Hospital Erasto Gaertner
      Feb 20, 2019

      NSCLC Stage IV, KRAS Gene Mutation, PD-1 Antibody Trial (SHR-1210, Apatinib, Pemetrexed)

      Unknown status
      • NSCLC Stage IV
      • +3 more
      • (no location specified)
      Jan 17, 2019